Plasma Fractionation Market Size, Share, By Product (Albumin, Immunoglobulins, Coagulation Factors, Protease Inhibitors, and Others), Method (Centrifugation, Depth Filtration, Chromatography, and Others), Application (Neurology, Hematology, Oncology, Immunology, Pulmonology, and Others), End-User (Hospitals and Clinics, Clinical Research Laboratories, Research Institutions, and Others), and Region - Trends, Analysis, and Forecast till 2035

The Rise in the Aging Population is Skyrocketing the Market Growth

As the aging population grows, so does the need for plasma-based treatments to manage age-related health issues. Specifically, older adults are more probable to develop rare disorders and chronic diseases that frequently require treatment with plasma-derived therapies such as coagulation factors and immunoglobulins, which are obtained through plasma fractionation. This is the main factor driving the growth of the plasma fractionation market.